James P. Allison, Ph.D.
Areas of Research
- Immunology Research
- Immunotherapy Research
- Melanoma Research
- Pancreatic Cancer Research
- Chemotherapy Research
- Radiation Therapy Research
- Prostate Cancer Research
- Epigenetics Research
- Targeted Therapy Research
The Allison Lab researches the fundamental mechanisms of T cell activation and regulation through cell surface receptors of the T cells and the antigen presenting cells with which they interact. The lab also investigates the mechanisms through which alterations in cell surface receptor signaling affect the cancer immune response.
Allison awarded Nobel Prize
Congratulations to our own Jim Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his pioneering work in immunotherapy.Learn more about his groundbreaking work
Work in the Allison lab takes advantage of the latest technology, including CyTOF and single-cell profiling of immune cells, and collaborations with some of the world’s finest clinical oncologists at MD Anderson. The end goal of work in my lab is to provide knowledge of the immune system that serves to guide the next generation of immunotherapy, including synergistic combinations of immunotherapy with other treatment modalities to make this the last generation to know the devastation of cancer.
Meet the Team
Allison Lab, April 2020, practicing responsible and productive social distancing. top row: (left to right) James Mancuso, Stephen Mok, Didem Çobanoğlu;
second row: Renee Chin, Jim Allison, Naveen Sharma;
bottom row: Kenny Dao, Tomi Atolagbe, Alexandria Cogdill.
not shown: Shirley Lindsey, Dongrui Wang